RecruitingNCT05345483

REscue Stenting With CREDO® Heal for Recanalisation After Unsuccessful Thrombectomy (RECHRUT)


Sponsor

Acandis GmbH

Enrollment

153 participants

Start Date

Jan 25, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Goal of the study is to evaluate the efficacy and safety of acute permanent stenting of symptomatic intracranial stenosis following unsuccessful recanalization by thrombectomy in acute ischemic stroke with large vessel occlusion using the self-expandable CREDO® heal Stent.


Eligibility

Min Age: 18 Years

Inclusion Criteria8

  • Patients, treated with CREDO® heal according to IFU
  • Over 18 years old
  • With acute persistent vascular occlusion due to high grade intracranial artery stenosis in the anterior or posterior circulation for which alternative therapy concepts are not considered or fail
  • With suspected underlying stenosis of the occluded artery, which is suitable for PTA and stenting according to the treating physician's assessment and/or persistent occlusion after failed recanalization by mechanical thrombectomy of the target region
  • With small to moderate infarct core prior to initiation of thrombectomy (CT ASPECTS 6-10, DWI lesion < 70 ml)
  • With symptoms onset less than 24 hours before start of the procedure
  • Treated with study device following at least one futile mechanical recanalization attempt with a stent retriever, direct aspiration or combination of both
  • With pre-stroke disability mRS 0-2

Exclusion Criteria4

  • Any contraindication according to IFU and patients:
  • With atherosclerotic (probable according to clinical, anamnestic or laboratory chemical testing) vessel constrictions (high-grade intracranial stenoses > 70 %) with significant circulatory disturbance (haemodynamic infarct pattern and signs of restricted collaterals) and recurrent symptoms in spite of medical therapy
  • With contraindication against treatment with anti-platelet medication
  • Participating in another trial

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICERescue stenting with CREDO heal Stent together with NeuroSpeed PTA Balloon Catheter

Rescue stenting with CREDO heal Stent together with NeuroSpeed PTA Balloon Catheter


Locations(17)

Institut für Radiologie und Neuroradiologie, Klinikum Aschaffenburg-Alzenau

Aschaffenburg, Germany

Klinik für Diagnostische Radiologie und Neuroradiologie; Universitätsklinikum Augsburg

Augsburg, Germany

Klinik für Diagnostische und Interventionelle Neuroradiologie; Universitätsklinikum Bonn

Bonn, Germany

Institut für Diagnostische und Interventionelle Radiologie, Neuroradiologie und Nuklearmedizin, Klinikum Bremerhaven-Reinkenheide

Bremerhaven, Germany

Institut und Poliklinik für Diagnostische und Interventionelle Neuroradiologie, Universitätsklinikum Dresden

Dresden, Germany

Klinik für Radiologie und Neuroradiologie, Sana Klinikum

Duisburg, Germany

Diagnostische und interventionelle Radiologie, Helios Klinikum Erfurt

Erfurt, Germany

Diagnostische und Interventionelle Neuroradiologie, Universitätsmedizin Halle

Halle, Germany

Abteilung für Radiologie, Neuroradiologie und Nuklearmedizin, Asklepios Klinikum Altona

Hamburg, Germany

Klinik und Poliklinik für Neuroradiologische Diagnostik und Intervention, Universitätsklinikum Hamburg-Eppendorf

Hamburg, Germany

Radiologie / Neuroradiologie, Askleopis Klinik St. Georg

Hamburg, Germany

Klinik für Neuroradiologie, Westpfalz-Klinikum

Kaiserslautern, Germany

Abteilung für Radiologie und Nuklearmedizin, Sana Kliniken

Lübeck, Germany

Interventionelle Neuroradiologie, Universitätsklinikum Münster

Münster, Germany

Institut für Radiologie und Neuroradiologie, Evangelisches Krankenhaus Oldenburg

Oldenburg, Germany

Klinik für Radiologie, Neuroradiologie und Nuklearmedizin, Klinikum Vest

Recklinghausen, Germany

Institut für Diagnostische und Interventionelle Neuroradiologie, Städtisches Klinikum

Solingen, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05345483


Related Trials